Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.85ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.66 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.72 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.133 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.5.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.7 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.33.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.493ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.2 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.640.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.352ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.251ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.443ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.495ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.294ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.453ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.350ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.304ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.315ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.516ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.354ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.426ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.402ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.424ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.264ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.581ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.330ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.205ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.177ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.301ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.308ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.210ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.325ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.116ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.496ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.49 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.273ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used